September 29, 2020 04:00 ET | Source: Fior Markets
Newark, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, theglobal cord blood banking market is expected to grow from USD 16.88 billion in 2019 and to reach USD 25.90 billion by 2027, growing at a CAGR of 5.5% during the forecast period 2020-2027.
The global cord blood banking market is witnessing significant growth from recent years. This growth is attributed to the rising awareness about therapeutic applications of cord blood, government initiatives and funding in developed economies, increasing prevalence of life-threatening genetic diseases, and growing clinical trials in regenerative medicines. A growing number of investors and genetic disorders will propel the market for cord blood banking.
The blood that stays in the placenta and umbilical cord post-delivery is known as cord blood. A process of collecting the cord blood and cryogenically freezing and extracting the stem cells and other cells of the immune system for the potential future medical use is known as cord blood banking. It consists of a rich source of stem cells that can treat various genetic diseases. A very small amount of cord blood can be collected from a single umbilical cord. These umbilical cord contain a large number of stem cells and is only the type of stem cells stored for future use. The medical use of stem cells and immune system cells in cord blood is expanding rapidly. The cord blood banking process includes the collection process through storage and newborn stem cells for future medical purposes.
The global cord blood banking market is expected to witness significant growth, owing to the increasing number of facilities, increasing use of cord blood in the treatment of chronic diseases, and rising prevalence of chronic diseases. The factors restraining the market growth are lack of uniformity in regulatory policies, large out-of-pocket expenditure, and low acceptance rate in developing countries. Increasing research concerns about cord blood application for the treatment of genetic and idiopathic disorders will provide market growth opportunities.
DOWNLOAD FREE SAMPLE REPORT AThttps://www.fiormarkets.com/report-detail/418891/request-sample Key players operating in global cord blood banking market are CBR Systems, Singapore Cord Blood Bank, Cryo-Save, ViaCord LLC, Global Cord Blood Corporation, Jeevan Stem Cell Foundation, LifeCell, Cordlife, Americord, and FamiCord. To gain a significant market share in the global cord blood banking market, the key players are now focusing on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint venture, collaborations, and partnership. FamiCord and Cryo-Save are the major players operating in cord blood banking.
Public cord blood bank segment dominated the market and held the largest market share of 58.2% in the year 2019 On the basis of type of bank, the global cord blood banking market is segmented into public and private. Public cord blood bank segment dominated the market and held the largest market share of 58.2% in the year 2019. This growth is attributed to various funding initiatives, and various government initiatives for encouraging expectant mothers to donate cord blood cells in public banks. The private cord blood banks are expected to witness significant growth, owing to the growing awareness among expectant parents and high demand to safeguard the health of family members.
Storage segment dominated the market and held the largest market share of 51.26% in the year 2019 On the basis of services, the global cord blood banking market is segmented into processing and storage. Storage segment dominated the market and held the largest market share of 51.26% in the year 2019. This growth is attributed to the increasing number of expectant parents utilizing the preservation of newborn cord blood cells. The processing segment is expected to witness significant growth due to various technological advancements in cord blood processing methods.
Blood disorders segment dominated the market and held the largest market share of 26.7% in the year 2019 On the basis of application, the global cord blood banking market is segmented into cancer, blood disorders, immuno-deficiency disorders, metabolic disorders, and bone marrow failure syndrome. Blood disorders segment dominated the market and held the largest market share of 26.7% in the year 2019. This growth is attributed to the increasing application of cord blood cells in the treatment of blood disorders and the increasing prevalence of beta-thalassemia. Immuno-deficiency disorders are expected to witness significant growth, owing to the rapid and reliable recovery of immune function, low viral transmission rate, and low risk of graft versus host diseases.
Research institute segment dominated the market and held the largest share of 41.5% in the year 2019 On the basis of end-user, the global cord blood banking market is segmented into hospitals, research institutes, and specialty clinics. Research Institute segment dominated the market and held the largest share of 41.5% in the year 2019. This growth is attributed to the growing pervasiveness of genetic disorders and growth in the number of clinical trials for exploring new diseases. Hospitals segment is expected to witness significant growth, owing to the advancement in cord blood banking, increasing prevalence of genetic diseases.
Browse full report with TOC athttps://www.fiormarkets.com/report/cord-blood-banking-market-by-type-of-bank-418891.html
Regional Segment of Cord Blood Banking Market
On the basis of geography, the global cord blood banking market is classified into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America held the major share of 25.8% in the year 2019. This growth is attributed to the presence of a large number of genetic disorders, continuous efforts by the researchers to explore new therapeutic applications of cord blood cells. The Asia-Pacific region market is anticipated to witness significant growth, owing to the growth potential in emerging economies like China and India due to the higher birth rate.
Request for Customization:https://www.fiormarkets.com/enquiry/request-customization/418891
About the report: The global cord blood banking market is analysed on the basis of value (USD billion). All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insights of the market. The study includes porters five forces model, attractiveness analysis, raw material analysis, and competitors position grid analysis.
For Instant Purchase:https://www.fiormarkets.com/checkout.html?reportid=418891&type=single
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us onsales@fiormarkets.comor +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
About Fior Markets
Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.
Contact Us
Avinash D Head of Business Development Phone:+1-201-465-4211 Email:sales@fiormarkets.com Web:www.fiormarkets.com
To Read Top Industries Reports, Visit our Affiliated Website: https://www.marketquest.biz
Related Reports
Antimicrobial Susceptibility Test Market - https://www.fiormarkets.com/report/antimicrobial-susceptibility-test-market-byproduct-consumables-automated-laboratory-418813.html Autologous Cell Therapy Market - https://www.fiormarkets.com/report/autologous-cell-therapy-market-by-source-bone-marrow-418814.html Autosampler Market - https://www.fiormarkets.com/report/autosampler-market-by-product-autosampler-systems-autosampler-accessories-418815.html Surgical Sealants and Adhesives Market - https://www.fiormarkets.com/report/surgical-sealants-and-adhesives-market-by-type-synthetic-418858.html
Read the original:
Global Cord Blood Banking Market Is Expected to Reach USD 25.90 billion by 2027 : Fior Markets - GlobeNewswire
- Hematologist/Stem Cell Biologist to Direct Hematology and Cellular Therapy at Cedars-Sinai - Newswise - December 1st, 2020
- Boston Celtics Kemba Walker will miss time after stem cell injection in left knee, will be re-evaluated in J - MassLive.com - December 1st, 2020
- Stem cell therapy in coronavirus disease 2019: current evidence and future potential - DocWire News - December 1st, 2020
- Hematologist Discusses the Impact a Myeloma CAR T-Cell Approval Would Have on the Treatment Landscape - DocWire News - December 1st, 2020
- Sphingosine 1-phosphate Receptor Modulator ONO-4641 Regulates Trafficking of T Lymphocytes and Hematopoietic Stem Cells and Alleviates Immune-Mediated... - December 1st, 2020
- New Drug Could Improve Effectiveness of Stem Cell Therapy - Pain News Network - December 1st, 2020
- Are stable producer cells the future of viral vector manufacturing and when will allogeneic cell therapy take hold? - BioPharma-Reporter.com - December 1st, 2020
- How Stem Cell Therapy Market Will Dominate In Coming Years? Report Covering Products, Financial Information, Developments, Swot Analysis And... - December 1st, 2020
- The Promise of Using Cell Cultures To Fight SARS-CoV-2 - Technology Networks - December 1st, 2020
- Coronavirus Updates: The Latest Treatments and Vaccines - GovTech - December 1st, 2020
- HCT Deemed More Favorable for MDS That Is High Risk - Cancer Therapy Advisor - December 1st, 2020
- Mini kidneys bioprinted in the lab - Lab + Life Scientist - December 1st, 2020
- Canine Stem Cell Therapy Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2026 - The Haitian-Caribbean News Network - December 1st, 2020
- Stem Cell Therapy Market Size, Share & Trends Analysis Report By Product Types, And Applications Forecast To 2026 - Cheshire Media - December 1st, 2020
- Animal Stem Cell Therapy Market Potential Growth, Size, Share, Demand and Analysis of Key Players Research Forecasts to 2026 - The Haitian-Caribbean... - December 1st, 2020
- Stem Cell Therapy Market Size, Growth, Demand, Opportunities & Forecast To 2025 - Cheshire Media - November 29th, 2020
- Mapping out the mystery of blood stem cells - Science Codex - November 26th, 2020
- Scientists Reveal a New Drug That Directs Stem Cells To Desired Sites - Science Times - November 26th, 2020
- Celularity Announces Dosing of First Patient in Phase I Study of Human Placental Hematopoietic Stem Cell-Derived Natural Killer Cells (CYNK-001) in... - November 26th, 2020
- The stem/progenitor landscape is reshaped in a mouse model of essential thrombocythemia and causes excess megakaryocyte production - Science Advances - November 26th, 2020
- Novartis bags Mesoblast's stem cell therapy for ARDS, including in Covid-19, in a deal worth up to $1.2B+ - Endpoints News - November 24th, 2020
- Global Stem Cells Market is estimated to account for US$ 18289.9 Mn by end of 2027, Says Coherent Market Insights (CMI) - Business Wire - November 24th, 2020
- Adherence to Allogeneic Stem Cell Transplantation to Improve Survival in Myelodysplastic Syndromes - Hematology Advisor - November 24th, 2020
- Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)-study protocol for a... - November 24th, 2020
- Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing... - November 24th, 2020
- CAR T-cell therapy treatment helps cancer patient beat near impossible odds - ABC News - November 24th, 2020
- Correlation of whole-bone marrow dual-time-point (18)F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in... - November 24th, 2020
- Late Effects of Therapy Plague Many Patients Who Survived AML as Youths, Young Adults - AJMC.com Managed Markets Network - November 24th, 2020
- Rescue Therapy with Bendamustine and Other Agents May Result in High Response Rates in Relapsed or Refractory NHL - Curetoday.com - November 24th, 2020
- Genenta to Appoint Stephen Squinto, Experienced Biotech Executive and Investor, as Chairman - BioSpace - November 24th, 2020
- Exploring First-line Therapies in Peripheral T-Cell Lymphomas - Targeted Oncology - November 24th, 2020
- Israeli Scientists Discover Oxygen Beauty Treatment That Can Make You Look 25 Years Younger - All You Need to - India.com - November 24th, 2020
- Novartis licenses phase 3 COVID-19 cell therapy from Mesoblast - FierceBiotech - November 22nd, 2020
- Benefits of Hematopoietic Stem Cell Transplantation in Advanced Myelodysplastic Syndromes - Hematology Advisor - November 22nd, 2020
- YOUR HEALTH: Your body may already have the answer to knee pain - WQAD.com - November 22nd, 2020
- Providing CAR T-Cell Therapy for Patients With DLBCL During COVID-19 - Targeted Oncology - November 22nd, 2020
- BioRestorative Therapies Emerges from Chapter 11 Reorganization - OrthoSpineNews - November 22nd, 2020
- Stem Cell Therapy Market 2020 Trends, Market Share, Industry Size, Growth, Sales, Opportunities, Analysis and Forecast To 2026 - The Daily... - November 22nd, 2020
- Animal Stem Cell Therapy Market 2020 Impact of COVID-19 | Size, Share & Latest Trends, Analysis Report by Manufacturers, Application, Type and... - November 22nd, 2020
- Canine Stem Cell Therapy Market 2020 impact of COVID-19 on Industry Size, Share, Global Analysis, Development Status, Regional Trends, Opportunity... - November 22nd, 2020
- Stem Cell Therapy Market, Share, Application Analysis, Regional Outlook, Competitive Strategies & Forecast up to 2026 - The Daily Philadelphian - November 22nd, 2020
- gift of life marrow registry announces new center for cell and gene therapy - The Boca Raton Tribune - November 22nd, 2020
- Global Canine Stem Cell Therapy Industry Market Analysis, Key Company Profiles, Types, Applications and Forecast To 2026 - Royal Sutton News - November 22nd, 2020
- Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis? - DocWire News - November 22nd, 2020
- Glycostem initiates phase I/IIa (pivotal) trial to evaluate the safety and efficacy of oNKord in patients with Acute Myeloid Leukemia (AML) -... - November 22nd, 2020
- Impact Analysis of Covid-19 On Global Stem Cell Therapy Market Continues to Expand to Support Development and Top Players: Magellan, Medipost Co.,... - November 22nd, 2020
- Adrenoleukodystrophy Treatment Market: Rising awareness about rare diseases to drive the market - BioSpace - November 22nd, 2020
- AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update - The Baytown Sun - November 16th, 2020
- Mesenchymal stem cells in the treatment of COVID-19-progress and challenges - DocWire News - November 16th, 2020
- The Animal Stem Cell Therapy market to fill the growth bill in the next decade - The Think Curiouser - November 16th, 2020
- Malaysia Animal Stem Cell Therapy Market Size 2020 | Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2027 - Eurowire - November 16th, 2020
- Addenbrooke's becomes first regional centre to offer CAR-T cell treatment for cancer patients - Cambridge Network - November 16th, 2020
- Stem Cell Therapy Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 - The Daily Philadelphian - November 16th, 2020
- Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review - DocWire News - November 16th, 2020
- Global cryotherapy market size to reach USD 6.72 billion by 2026 - GlobeNewswire - November 16th, 2020
- Stem Cell Therapy Market 2020 Future Growth Factors and Opportunities by 2025 - PRnews Leader - November 16th, 2020
- Stem Cell Therapy Market 2020 Trends, Growth Insight, Share, Competitive Analysis, Statistics, Regional and Global Industry Forecast To 2025 - PRnews... - November 16th, 2020
- BeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for... - November 16th, 2020
- Stem Cell Banking Market To See Massive Growth By 2027| Cryo-Save AG, StemCyte India Therapeutics, SMART CELLS PLUS, Vita 34, LifeCell - PRnews Leader - November 9th, 2020
- It's time for Kentucky to talk to expectant parents about benefits of cord blood banking - Courier Journal - November 9th, 2020
- Global Stem Cell Therapy Market 2020 : Analysis of Expansion Strategy on Industry, Growth Factors and Expected CAGR Of Top Leaders, Upcoming... - November 9th, 2020
- Stem Cell Banking Market 2020 analysis with Key Players, Applications, Trends and Forecasts by 2028|Esperite, Caladrius Biosciences, Via Cord, CBR... - November 9th, 2020
- Doctors Consider Convalescent T Cell Therapy for COVID-19 - The Scientist - November 7th, 2020
- Canine Stem Cell Therapy Market Analysis, Latest Trends and Regional Growth Forecast by Types and Applications 2020 - TechnoWeekly - November 7th, 2020
- Cancer Stem Cell Therapy Market: Industry Trends and Developments 2020-2025 - Zenit News - November 7th, 2020
- Stem Cell Therapy Market 2020: Size, Professional Survey, and Forecast to 2025 - PRnews Leader - November 7th, 2020
- The Adipose Tissue Derived Stem Cells market to grow in the wake of incorporation of the latest technology - The Think Curiouser - November 7th, 2020
- Novel Targeted Drugs are Changing the Treatment of Diffuse Large B-Cell Lymphoma - Curetoday.com - November 7th, 2020
- Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease - GlobeNewswire - November 7th, 2020
- Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American... - November 7th, 2020
- bluebird bio to Present Data from Gene and Cell Therapy Programs During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition -... - November 7th, 2020
- Voters approve stem cell research bonds, but other health care measures defeated - State of Reform - State of Reform - November 5th, 2020
- Stem cells key to ALS therapy - Agoura Hills Acorn - November 5th, 2020
- Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling. - UroToday - November 5th, 2020
- New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation - DocWire News - November 5th, 2020
- Emerging Trends in Global Canine Stem Cell Therapy Market Report 2020,Deeply Analyzes Share, Types, Applications and Future Demands by Key Players-... - November 5th, 2020
- Dr. Braunschweig on Selecting Between Transplant and CAR T-Cell Therapy in DLBCL - OncLive - November 5th, 2020
- Canine Stem Cell Therapy Market Size, Share Analysis by Manufacturers, Regions, Type and Application to 2026 - PRnews Leader - November 5th, 2020
- Stem Cell Therapy Market Insights Global Analysis and Forecast by (2020 2027) - The Think Curiouser - November 5th, 2020
- Animal Stem Cell Therapy Consumption Market To Observe Exponential Growth By 2020-2027 | Verified Market Research - Eurowire - November 5th, 2020
